Rabeprazole Sodium / Levosulpiride Injection 20mg + 75mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20mg + 75mg
Reference Brands: Rabeloc Plus (India/LATAM)
Category: Gastrointestinal Drugs
Levosulpiride + Rabeprazole is used in the treatment of gastroesophageal reflux disease (acid reflux), intestinal ulcers and irritable bowel syndrome.
Product Description:
Rabeprazole Sodium (20 mg) and Levosulpiride (75 mg) is a potent combination capsule/tablet formulated to provide comprehensive relief from acid-related gastrointestinal disorders. This medication is primarily used to manage gastroesophageal reflux disease (GERD), acidity, heartburn, and indigestion. By combining two complementary actions, it addresses both excess stomach acid and impaired gastric motility.
Rabeprazole Sodium, a proton pump inhibitor, works by blocking the acid-producing pumps in the stomach lining, thereby reducing gastric acid secretion and alleviating symptoms such as heartburn, regurgitation, and esophageal irritation. Levosulpiride, a prokinetic agent, enhances gastrointestinal motility and accelerates gastric emptying, which helps relieve bloating, nausea, and vomiting.
Typically prescribed to be taken once daily on an empty stomach before meals, this combination provides rapid and effective symptom control while promoting better digestive health. It is especially useful for patients who experience persistent acidity, delayed gastric emptying, or related gastrointestinal discomfort. When used under medical supervision, Rabeprazole Sodium and Levosulpiride capsules/tablets offer a convenient and reliable solution for managing chronic and acute digestive disorders.
Rabeprazole Sodium / Levosulpiride Injection — third party manufacturing & bulk supply
Rabeprazole Sodium / Levosulpiride Injection 20mg + 75mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Rabeprazole Sodium / Levosulpiride Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Rabeprazole Sodium / Levosulpiride Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Rabeprazole Sodium / Levosulpiride Injec... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Rabeprazole Sodium / Levosulpiride is a combination medication used to treat acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), acidity, heartburn, indigestion, bloating, and nausea. Rabeprazole, a proton pump inhibitor, reduces stomach acid production, while Levosulpiride, a prokinetic agent, improves gastric motility and helps relieve nausea and vomiting. This combination provides comprehensive relief from both acid-related irritation and delayed gastric emptying.
It is made from Rabeprazole Sodium, a proton pump inhibitor that blocks acid-producing pumps in the stomach lining, and Levosulpiride, a dopamine D2 receptor antagonist that enhances gastrointestinal motility and controls nausea.
Common trade names include Rabeloc‑M, Rabimed‑L, Rabesulp, Rabep‑L, and Levosrab.
This combination is manufactured by various pharmaceutical companies in India, including Sun Pharma, Torrent Pharmaceuticals, Abbott, Alkem Laboratories, Cipla, and Intas Pharmaceuticals, depending on the brand.
The generic name is Rabeprazole Sodium Levosulpiride Tablet.
Brand names include Rabeloc‑M, Rabimed‑L, Rabesulp, Rabep‑L, and Levosrab.
These tablets are primarily manufactured in India and exported to regions such as Asia, Africa, and Latin America, depending on regulatory approvals and market demand.
Related Products
Bismuth Subsalicylate
Strength:
262 mg, 525 mg
Form: Oral suspension / Tablet
Reference Brands: Pepto-Bismol (USA/LATAM),
View Details
Quick Response Guaranteed | Verified Suppliers
